CELT Pharmacology

Pharmacology within the Centre of Excellence for Long-acting Therapeutics. Developing long-acting medicines for prolonged therapy.

[CELT Pharmacology @CELT_pharm]

If you are showing symptoms of #COVID19 and want to help develop new medicines then join AGILE - a clinical trial that tests new drugs and identifies faster than ever before those compounds which could be game changers in the battle against COVID-19. https://t.co/nci9mJcxhz

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

💡 The #LONGEVITY project aims to be transformational for healthcare provision in low and middle-income countries by developing #longacting formulations to drastically reduce the burden #malaria, #tb and #hepatitisC imposes on those communities.

👉https://t.co/wRoSubL4kr

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

🔎 Find out about #LONGEVITY - our ambitious project designed to develop #longacting drug formulations for;

✔️ #malaria prevention
✔️ #tb prevention
✔️ a single-injection cure for #hepatitisC

👉https://t.co/wRoSubL4kr

Funded by @UNITAID 🤝

[Kudos @GrowKudos]

New research from @CELT_pharm @LivUni @EPSRC in collaboration with @UNITAID @UppertonLtd: “Long-Acting #Injectable #Medicine as Potential Route to #COVID-19 Therapy”. Explore their project page https://t.co/W81Gqjg1hR

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Today is #InternationalYouthDay! In 2017 children under five accounted for 61% of #malaria deaths worldwide. The #LONGEVITY project aims to tackle the issue of non-adherence and control of the disease to drastically reduce these statistics.

👉https://t.co/S2vm7oGFGq

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

The AGILE (@LivAgile) Platform allows us to test new #COVID19 treatments faster than ever before with the aim to find affordable drugs which can be accessed by communities globally.

🎞️Watch our infographic to find out more
👉https://t.co/ZFWGMvPAwG
@LSTMnews, @SouthamptonCTU

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

📰 Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters

Read the full preprint 👉 https://t.co/26KpoxtXdK

@molvirol @_AndrewOwen_

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Visit our 'About Us' page to learn more about the centre, including our mission statement, what we value most in our research, our most critical challenges and how we will overcome them.
👉 https://t.co/Y9Npvjjhi3
#longacting #pharmacology #chemistry #longactingtherapeutics

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Brilliant collaborative effort involving CELT researchers investigating novel nanoparticle vaccination approaches for #COVID19 resulting in an enhanced and protective response in mice. Great work from all involved! Read the full paper here 👉 https://t.co/cfcTksr0yF #covidvaccine

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

The Nanotehrapeutics Hub at CELT has joined forces with @iiconNW to support companies looking to develop cutting-edge nanotherapeutics to combat infectious diseases and access the nanomedicine market. Find out more 👉 https://t.co/Rp4rQBX4P0
#nanotherapeutics
#infectioninnovation

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Find out about #LONGEVITY - our ambitious project developing the long acting pipeline to establish medicines for malaria, TB and hepatitis C virus with infrastructure for sustainable translational capacity.
👉https://t.co/j7BRxbqfNR

#longactingtherapeutics

Funded by @UNITAID 🤝

[MedicinesPatentPool @MedsPatentPool]

💻> Register to @WHO @UNITAID @MedsPatentPool online session on #HepC treatment for #LMICs during #WHA74!
✅Latest tools & publications from @WHO @UNITAID
✅Feedback from #Rwanda
✅Panel discussion w/countries & experts
⏰Wednesday 26 May, 1-2pm CET
👉 https://t.co/A3F37TAlfy

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

If you work in the field of #nanotherapeutics or have a related project, you could work with our Nanotherapeutics Hub and benefit from our analytical expertise and links to partner institutions to support your development.
Find out more 👉 https://t.co/AKfZgEKvWp

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Our friends over at @TAGTeam_Tweets and @afrocab_hiv are excited to share a call for a new long-acting technologies community advisory board focused on malaria, HCV, and latent TB infection. If you are interested visit their website for more info👉 https://t.co/2plSWlygZi

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

📨📨📨Keep up to date with CELT news, projects and research developments by subscribing to our mailing list to receive regular news updates straight to your inbox📨📨📨

Sign up here 👉 https://t.co/VQMNhVpOzi

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

In case you missed it: CELT researchers demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
Read the full news item here 👉 https://t.co/lLrRB1wryp
#longactingtherapeutics

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

📰CELT researchers demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
Read the full news item here 👉https://t.co/lLrRB1O2WZ
#longactingtherapeutics

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Congratulations to our brilliant colleague Usman Arshad who has passed his viva for his PhD thesis entitled 'Nanoparticle Interventions for Colorectal Cancer Liver Metastases: Optimisation of Irinotecan Therapy'. Well-deserved recognition for his incredible hard work. 👏👏👏

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

📨📨📨You can now sign up to our mailing list to receive the latest news, updates and events information from CELT📨📨📨
Follow the link to register 👉https://t.co/VQMNhVpOzi
#longactingtherapeutics

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

For more papers like this one visit our publications page where we have an archive of all #longactingtherapeutics papers written by CELT scientists...
👉https://t.co/9eiehpJCNk

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Our researchers have produced a paper detailing the nanoparticle formulation of a highly insoluble drug compound, niclosamide, with known anti SARS-CoV-2 activity as a cheap and scalable long-acting injectable antiviral candidate. https://t.co/GX1H96qFKt

#longactingtherapeutics